Brave Monarch worked three furlongs in 38.70 ( 6 of 8) Tuesday morning at Belmont. Mike said, "I got one more 3/8ths into him before going a half. He was full of run today; it was a little bit of rider error but I was very pleased with the work nonetheless. He could have very easily went in 37, but my exercise rider misjudged how fast he was going." Brave Monarch is scheduled to work four furlongs on Monday or Tuesday of next week. A late December debut at Aqueduct remains our target.
Phosphorescent
*Both ankles injected with hyaluronic acid earlier this week as part of Dr. Baker’s post surgical protocol. Hyaluronic acid stimulates the production of healthy joint fluid and decreases cartilage damage.
*In about a week, he will begin IRAP therapy to help reduce inflammation and to strengthen cartilage. Click here to learn more about the therapy
.*Later this he will begin a daily handwalking routine before starting daily turnout in the roundpen shortly thereafter.
*IRAP treatment is a three treatment series that takes place once a week. After each treatment, Phosphorescent will be on stall rest for two days before resuming turnout.
*Chamberlain Bridge, the horse we were ½ a length away from beating in the PA Governor’s Cup on July 31st won the Breeders’ Cup Turf Sprint (gr. II) on Saturday at Churchill Downs.
Mr. Fantasy
*Scheduled to have his second PRP treatment over the weekend.
*He’s been out in the dry lot for a few hours each day to enjoy the sunshine.
*In about two weeks, he will receive IRAP therapy to help reduce inflammation and to strengthen the cartilage in his ankles. Click here to learn more about the therapy.
*We are about one month into the 4-5 month projected out of training period.
The Defense Rests had another strong week of gallops in South Carolina and enjoyed the sunshine for a few hours each day when turned out in a small paddock on the farm. Kip indicated today that he’ll resume speedwork right around Thanksgiving.
Adventures in horse racing
Thursday, November 11, 2010
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.